摘要
丙型病毒性肝炎是肝硬化、肝细胞癌的重要病因之一。我国约有1000万例慢性丙型肝炎病毒(HCV)感染者,但是,我国仍有大约70%以上的HCV感染者并没有被发现。根据世界卫生组织提出到2030年消除病毒性肝炎作为公共卫生危害的目标,以及医疗机构是目前我国发现HCV感染者和患者的主要场所,我们制定了《丙型病毒性肝炎院内筛查管理流程》,希望促进医疗机构管理、临床、检验、感染控制的多学科、多部门联合,加强医疗机构对检出抗-HCV阳性就诊者的咨询和转诊,促进慢性丙型肝炎患者的诊断和抗病毒治疗。
Viral hepatitis C is one of the important causes of liver cirrhosis and hepatocellular carcinoma.There are approximately 10 million cases of chronic hepatitis C virus(HCV)infection in China.However,over 70%of HCV infections of China have not yet been detected.According to the goal of"eliminating viral hepatitis as a public health threat by 2030"of the World Health Organization Viral Hepatitis Strategy,and the fact that medical institutions remain the main places for detecting HCV infections or patients in China at present,we established the"In-hospital process for viral hepatitis C screening and management in China(Draft)",with intention to promote the multidisciplinary collaboration and cooperation among the departments of clinic,laboratory,infection control,management,and etc.in medical institutions,and strengthen consultation and referral of patients with detected HCV antibodies and advance the diagnosis and antiviral treatment of patients with chronic hepatitis C.
作者
中联肝健康促进中心
中华医学会肝病学分会
中华医学会检验医学分会
中国医院协会医院感染管理专业委员会
魏来
徐小元
李六亿
潘世扬
封波
高燕
关秀茹
李明阳
陈仲丹
庄辉
China Liver Health;Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Laboratory Medicine,Chinese Medical Association;Hospital Infection Management Committee of Chinese Hospital Association;Wei Lai;Xu Xiaoyuan;Li Liuyi;Pan Shiyang;Feng Bo;Gao Yan;Guan Xium;Li Mingyang(不详;Hepatopancreatobilimy Center,Beijing Tsinghua Changgiing Hospital,Tsinghua University,China Liver Health,Beijing 102218,China;Department of Infectious Disease,Peking University First Hospital,Peking University,Beijing 100034,China;Department of Hospital Infection Control Peking University First Hospital,Peking University,Beijing 100034,China;Department of Laboratory Medicine,the First Affiliated Hospital,Nanjing Medical University,Manjing 210029,China;Peking University Hepatology Institute,Peking University,Beijing 100034,China;Peking University-People's Hospital Peking University,Beijing 100044,China;the First Affiliated Hospital of Harbin Medical University,Harbin 150001,China;China Liver Health,Beijing 100853,China)
出处
《中华肝脏病杂志》
CSCD
北大核心
2021年第4期319-325,共7页
Chinese Journal of Hepatology
关键词
丙型肝炎
流程
筛查
诊断
治疗
Hepatitis C
Algorithm
Screen
Diagnosis
Treatment
